Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Hypertension. 2022 Aug 23;79(11):e135–e142. doi: 10.1161/HYPERTENSIONAHA.122.19302

Table 1.

Overview of the Analytical Sample

A. Diabetes Mellitus sample
Overall HBH NM p-value
n (n=7628) (n=5346) (n=2282)
Age (mean (SD)) 36.07 (12.85) 33 (12.11) 43.25 (11.60) <0.001
Male (%) 5393 (70.7) 3460 (64.7) 1933 (84.7) <0.001
Race & ethnicity (%) <0.001
 Black, non-Hispanic 1964 (25.7) 1232 (23.0) 732 (32.1)
 Hispanic 1196 (15.7) 979 (18.3) 217 (9.5)
 White, non-Hispanic 3574 (46.9) 2516 (47.1) 1058 (46.4)
 Other* 894 (11.7) 619 (11.6) 275 (12.1)
Insurance category (%)
 Government 1378 (18.1) 839 (15.7) 539 (23.6)
 Private 2669 (35.0) 1715 (32.1) 954 (41.8)
 Other/uninsured 3581 (46.9) 2792 (52.2) 789 (34.6)
HTN at baseline (%) 230 (3.0) 74 (1.4) 156 (6.8) <0.001
Body mass index 27.09 (6.32) 27.44 (6.67) 26.59 (5.75) <0.001
CD4 (cells/mL) [MD [IQR]) 462 [283, 668] 601 [409, 788] 435 [257, 628] <0.001
Viral load at baseline (MD [IQR]) 81 [20, 26427] 41 [20, 29667] 161.5 [36, 20249] <0.001
<100 copies/mL on first VL (%) 3901 (51.1) 2875 (53.8) 1026 (45.0) <0.001
<100 copies/mL on last VL (%) 6629 (86.9) 4676 (87.5) 1953 (85.6) 0.028
Incident DM (%) 230 (3.0) 74 (1.4) 156 (6.8) <0.001
Time to DM (MD [IQR]) 3.16 [1.67, 6.25] 2.69 [1.45, 5.14] 5.02 [2.46, 7.64] <0.001
Total number of VL (MD [IQR]) 9 [5, 15] 7 [5, 12] 15 [8, 23] <0.001
Time from First to Last VL (years, MD [IQR]) 3.24 [1.70, 6.47] 2.70 [1.45, 5.19] 5.37 [2.65, 7.77] <0.001
B. Hypertension sample
Overall HBH NM p-value
n (n=7450) (n=5318) (n=2132)
Age (mean (SD)) 35.73 (12.70) 32.89 (12.03) 42.80 (11.53) <0.001
Male (%) 5240 (70.3) 3438 (64.6) 1802 (84.5) <0.001
Race/etdnicity (%) <0.001
 Black, non-Hispanic 1892 (25.4) 1214 (22.8) 678 (31.8)
 Hispanic 1196 (16.1) 980 (18.4) 216 (10.1)
 White, non-Hispanic 3479 (46.7) 2503 (47.1) 976 (45.8)
 Other* 883 (11.9) 621 (11.7) 262 (12.3)
Insurance category (%)
 Government 1319 (17.7) 827 (15.6) 492 (23.1)
 Private 2575 (34.6) 1698 (31.9) 877 (41.1)
 Other/uninsured 3556 (47.7) 2793 (52.5) 763 (35.8)
DM at baseline (%) 496 (6.7) 136 (2.6) 360 (16.9) <0.001
 Body mass index 26.98 (6.24) 27.37 (6.61) 26.37 (5.54) <0.001
CD4 (cells/mL) (MD [IQR]) 458 [278, 666] 596 [408, 790] 429 [253, 619] <0.001
Viral load at baseline (median [IQR]) 86.50 [20, 26938] 40 [20, 29567] 211 [42, 22804] <0.001
<100 copies/mL on first VL (%) 3785 (50.8) 2863 (53.8) 922 (43.2) <0.001
<100 copies/mL on last VL (%) 6460 (86.7) 4649 (87.4) 1811 (84.9) 0.005
Incident HTN (%) 496 (6.7) 136 (2.6) 360 (16.9) <0.001
Time to HTN (MD [IQR]) 3.05 [1.60, 6.01] 2.69 [1.44, 5.15] 4.53 [2.18, 7.42] <0.001
Total number of VL (MD [IQR]) 9 [5, 15] 7 [5, 12] 14 [8, 23] <0.001
Time from First to Last VL (years, MD [IQR]) 3.2 [1.68, 6.42] 2.71 [1.45, 5.20] 5.34 [2.54, 7.78] <0.001

Notes:

*-

Others include Asian, Pacific Islander, Multiracial, and Unspecified. DM – Diabetes mellitus, IQR – interquartile range, HBH – Howard Brown Health, HTN – hypertension, MD – median, NM – Northwestern Medicine. VL – viral load.